About Index Trending news
Lists
Pricing
OrbiMed

OrbiMed

Elsewhere

Investment profile

Geographical Focus
United States Israel
Markets focus
Medical Health Care Biotechnology
Stage Focus

Activity

Past year's investments
  • 25 rounds in the past year
  • $1,223,095,062 deployed in total
  • $48,923,802 avg per round
Latest rounds
  • TELA Bio: Private equity ($25M)
  • NeuroPace: Venture capital ($74M)
  • Azura Ophthalmics: Venture capital (Series B) ($16M)
Total funding
$63M in 4 rounds from 27 investors
By OrbiMed
$23M Venture Capital in Dec, 2016
Total funding
$330.8M in 14 rounds from 44 investors
By OrbiMed
$26.1M Post-IPO equity in Jan, 2017
Total funding
$550M in 5 rounds from 26 investors
By OrbiMed
$360M Series E in May, 2017
Total funding
$16M in 2 rounds from 5 investors
By OrbiMed
$10.5M Series C in Jun, 2015
Total funding
$4M in 1 rounds from 1 investors
By OrbiMed
$4M Venture Capital in Oct, 2015
Total funding
$81.1M in 4 rounds from 17 investors
By OrbiMed
$50M Series C in Nov, 2015
Total funding
$92M in 2 rounds from 7 investors
By OrbiMed
$74M Venture Capital in Oct, 2017
Total funding
$12.5M in 2 rounds from 2 investors
By OrbiMed
$2.5M Venture Capital in Jun, 2016
Total funding
An undisclosed amount in 1 rounds from 3 investors
By OrbiMed
undisclosed deal in Jan, 2016
Total funding
$102M in 3 rounds from 10 investors
By OrbiMed
$35M Series B in Apr, 2015
Exit Bioverativ, May 23, 2017
Total funding
$114.6M in 3 rounds from 3 investors
By OrbiMed
$45M Post-IPO equity in Aug, 2016
Total funding
$30M in 2 rounds from 6 investors
By OrbiMed
$20M Series C in Aug, 2016
Total funding
$125.7M in 3 rounds from 5 investors
By OrbiMed
$51.4M Series D in Jan, 2015
Total funding
$331.4M in 4 rounds from 9 investors
By OrbiMed
$40M Undisclosed in Mar, 2017
Total funding
$77.4M in 6 rounds from 13 investors
By OrbiMed
$30M Post-IPO equity in Apr, 2017
Total funding
$51M in 1 rounds from 3 investors
By OrbiMed
$51M Series A in Jan, 2016
Total funding
$29.5M in 1 rounds from 9 investors
By OrbiMed
$29.5M Series D in Jan, 2016
Total funding
$280M in 3 rounds from 10 investors
By OrbiMed
$30M Series C in Jun, 2017
Total funding
$8.5M in 2 rounds from 6 investors
By OrbiMed
$8M Series A in Jul, 2017
Total funding
$55M in 1 rounds from 5 investors
By OrbiMed
$55M Series C in Jul, 2016
Total funding
$81M in 2 rounds from 11 investors
By OrbiMed
$37M Series B in Aug, 2016
Total funding
$30M in 1 rounds from 5 investors
By OrbiMed
$30M Series D in Aug, 2016
Total funding
An undisclosed amount in 2 rounds from 7 investors
By OrbiMed
undisclosed deal in Jun, 2017
Total funding
$151.2M in 3 rounds from 7 investors
By OrbiMed
$45.6M Series B in Jan, 2017
Total funding
$60M in 1 rounds from 6 investors
By OrbiMed
$60M Series D in Dec, 2014
Total funding
$34.7M in 2 rounds from 4 investors
By OrbiMed
$26M Series C in Mar, 2017
Total funding
$30.9M in 1 rounds from 4 investors
By OrbiMed
$30.9M Series B in Nov, 2016
Total funding
$85M in 2 rounds from 15 investors
By OrbiMed
$50M Private equity in Sep, 2017
Total funding
$46.8M in 2 rounds from 8 investors
By OrbiMed
£23M Series B in Jan, 2017
Total funding
$40M in 2 rounds from 8 investors
By OrbiMed
$5M Series A in Jan, 2017
Total funding
$8M in 1 rounds from 4 investors
By OrbiMed
$8M Series A in Jan, 2017
Total funding
$78.3M in 4 rounds from 7 investors
By OrbiMed
$25M Private equity in Oct, 2017
Total funding
$148M in 2 rounds from 11 investors
By OrbiMed
$74M Series B in Feb, 2017
Total funding
$54.8M in 2 rounds from 10 investors
By OrbiMed
$45.5M Series D in Apr, 2017
Total funding
$45M in 1 rounds from 6 investors
By OrbiMed
$45M Series B in Jun, 2017
Total funding
$63M in 1 rounds from 6 investors
By OrbiMed
$63M Series A in Jul, 2017
Total funding
$16M in 1 rounds from 4 investors
By OrbiMed
$16M Series B in Oct, 2017
Total funding
$26M in 1 rounds from 5 investors
By OrbiMed
$26M Post-IPO equity in Sep, 2017
Total funding
$103M in 1 rounds from 5 investors
By OrbiMed
$103M Series A in Sep, 2017
Total funding
$42.5M in 1 rounds from 1 investors
By OrbiMed
$42.5M Private equity in Sep, 2017

Want to see the complete list?
Go Pro!